Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Otsuka Holdings Co., Ltd.
  6. Summary
    4578   JP3188220002

OTSUKA HOLDINGS CO., LTD.

(4578)
  Report
Delayed Japan Exchange  -  01:00:00 2023-02-06 am EST
4120.00 JPY   +0.81%
01/30Otsuka Pharmaceutical Co., Ltd. Files an Application in Japan for an Additional Indication for Rexulti
CI
01/09IMV Inc. Announces Planned 2023 Milestones to Advance Clinical Development of Lead Therapeutic, MVP-S
MT
01/08Lundbeck Wins US FDA's Priority Review Tag For Expanded Use Of Antipsychotic Drug In Dementia
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Japan Exchange
01/31/2023 02/01/2023 02/02/2023 02/03/2023 02/06/2023 Date
4158(c) 4153(c) 4115(c) 4087(c) 4120(c) Last
879 000 687 800 544 900 788 600 765 500 Volume
-0.29% -0.12% -0.92% -0.68% +0.81% Change
More quotes
Estimated financial data (e)
Sales 2022 1 698 B 12 967 M 12 967 M
Net income 2022 131 B 1 004 M 1 004 M
Net cash position 2022 323 B 2 468 M 2 468 M
P/E ratio 2022 16,9x
Yield 2022 2,43%
Sales 2023 1 773 B 13 544 M 13 544 M
Net income 2023 163 B 1 245 M 1 245 M
Net cash position 2023 413 B 3 153 M 3 153 M
P/E ratio 2023 13,6x
Yield 2023 2,48%
Capitalization 2 236 B 17 076 M 17 076 M
EV / Sales 2022 1,13x
EV / Sales 2023 1,03x
Nbr of Employees 33 226
Free-Float 65,4%
More Financials
Company
Otsuka Holdings Co, Ltd. is a holding company organised around 4 areas of activity: - manufacture and sale of pharmaceutical products (65.2% of sales): prescription drugs and intravenous solutions mainly for the treatment of central nervous system disorders, cancer, cardiovascular, gastrointestinal and ophthalmic diseases. In addition, the group sells diagnostic products and medical devices; - manufacture and sale... 
Read more
Sector
Pharmaceuticals
Calendar
02/14Earnings Release
More about the company
Ratings of Otsuka Holdings Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about OTSUKA HOLDINGS CO., LTD.
01/30Otsuka Pharmaceutical Co., Ltd. Files an Application in Japan for an Additional Indicat..
CI
01/09IMV Inc. Announces Planned 2023 Milestones to Advance Clinical Development of Lead Ther..
MT
01/08Lundbeck Wins US FDA's Priority Review Tag For Expanded Use Of Antipsychotic Drug In De..
MT
2022OTSUKA HOLDINGS CO., LTD. : Ex-dividend day for final dividend
FA
2022Otsuka Group Selected for CDP Climate Change A List
AQ
2022Otsuka Medical Devices and ReCor Medical Announce Submission of Application for Pre-Mar..
AQ
2022Otsuka Medical Devices Co., Ltd. and Recor Medical, Inc. Announce Submission of Applica..
CI
2022IN BRIEF: Clarify Pharma invests in two "trailblazing" companies
AN
2022ReCor Medical Announces Consistent Reduction of Blood Pressure in Pooled Analysis of Th..
BU
2022Otsuka's Nine-Month Attributable Profit Drops 12% on Higher Expenses, Impairment Loss
MT
2022Otsuka Holdings Co., Ltd. Revises Consolidated earnings Guidance for the Fiscal Year En..
CI
2022Otsuka Holdings Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending Decembe..
CI
2022Jefferies Adjusts Otsuka Holding's Price Target to 5,000 Yen From 5,100 Yen, Keeps at H..
MT
2022KalVista Pharmaceuticals Appoints Brian J.G. Pereira Chairman to Succeed Martin Edwards
MT
2022Otsuka Medical Devices Announces Results of RADIANCE II Pivotal Trial at TCT 2022 Annua..
AQ
More news
News in other languages on OTSUKA HOLDINGS CO., LTD.
01/30Otsuka Pharmaceutical Co., Ltd. (Otsuka) dépose une demande au Japon pour une indicatio..
01/09Il en faut peu pour être heureux
01/09En direct des marchés : Orange, Dassault Systèmes, Euroapi, Elis, ..
01/08Lundbeck obtient l'étiquette d'examen prioritaire de la FDA américaine pour l'utilisati..
2022La Banque centrale japonaise trouble les marchés mondiaux
More news
Analyst Recommendations on OTSUKA HOLDINGS CO., LTD.
More recommendations
ETFs positioned on OTSUKA HOLDINGS CO., LTD.ETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Nomura NEXT FUNDS TOPIX-17 PHARMACEUTICAL E...6.51%-1.58%-Japan
IShares MSCI Japan Minimum Volatility (ex-R...1.47%-1.10%-Japan
Fidelity International Value Factor ETF - USD1.09%-0.15%World
NEXT FUNDS Solactive Japan ESG Core Index E...0.97%2.76%-NC
Nikko Listed Index Fund Japanese Economy Co...0.73%-1.21%-Japan
More ETFs positioned on OTSUKA HOLDINGS CO., LTD.
Chart OTSUKA HOLDINGS CO., LTD.
Duration : Period :
Otsuka Holdings Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OTSUKA HOLDINGS CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Last Close Price 4 120,00 JPY
Average target price 4 754,55 JPY
Spread / Average Target 15,4%
EPS Revisions
Managers and Directors
Tatsuo Higuchi President, CEO & Representative Director
Yuko Makino Director & Head-Finance
Ichiro Otsuka Vice Chairman
Masanori Udagawa Executive Officer & Manager-IT Planning
Yukio Matsutani Independent Outside Director
Sector and Competitors
1st jan.Capi. (M$)
OTSUKA HOLDINGS CO., LTD.-5.06%16 939
SUN PHARMACEUTICAL INDUSTRIES LTD.2.67%29 987
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.-4.51%12 493
ONO PHARMACEUTICAL CO., LTD.-8.87%10 481
CIPLA LIMITED-4.99%10 031
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.17.17%6 330